Perspectives in animal health: Old targets and new opportunities

Journal of Medicinal Chemistry

Volumn 44, Issue 5, 2001, Pages 641-659

  Meinke, P T ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINO 2 [3 [3 (1 PIPERIDYLMETHYL)PHENOXY]PROPYLAMINO] 1 CYCLOBUTENE 3,4 DIONE; ALBENDAZOLE; ANTHELMINTIC AGENT; AVERMECTIN; AZADIRACHTIN; BAFILOMYCIN A1; CIMETIDINE; CYTHIOATE; DORAMECTIN; EPRINOMECTIN; FAMOTIDINE; FENTHION; FIPRONIL; FLUBENDAZOLE; IVERMECTIN; LEVAMISOLE; MILBEMYCIN; MILBEMYCIN D; MORANTEL; MOXIDECTIN; NEMADECTIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARAHERQUAMIDE; PERMETHRIN; PYRANTEL; PYRIPROXYFEN; RANITIDINE; SPINOSYN A; TIABENDAZOLE; UNINDEXED DRUG;

ANIMAL DISEASE; ANIMAL WELFARE; CAT; CATTLE; DOG; DRUG IDENTIFICATION; ECTOPARASITE; HORSE; HORSE DISEASE; INFESTATION; MEDICAL RESEARCH; NONHUMAN; OBESITY; REVIEW; SHEEP; STOMACH ULCER; SWINE; VETERINARY MEDICINE;

ANIMALS; ANTHELMINTICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-OBESITY AGENTS; ANTI-ULCER AGENTS; ANTIPARASITIC AGENTS; CAT DISEASES; CATS; DOG DISEASES; DOGS; FLEAS; FORECASTING; HORSE DISEASES; HORSES; TICK INFESTATIONS; VETERINARY DRUGS;

EID: 0035282626     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990564h     Document Type: Review

References (153)

1. Historical introduction
2. Target sites of anthelmintics
3. Activation and cooperative multi-ion block of single nicotinic-acetylcholine channel currents of Ascaris muscle by the tetrahydropyrimidine anthelmintic, morantel
4. Neuromuscular transmission in nematodes and anthelmintic drug action
5. The action of pyrantel as an agonist and an open channel blocker at acetylcholine receptors in isolated Ascaris suum muscle vesicles
6. Ivermectin, a new broad-spectrum antiparasitic agent
7. Efficacy of ivermectin and pyrantel pamoate combined in a chewable formulation against heartworm, hookworm, and ascarid infections in dogs
8. Recent progress in the synthesis of avermectins and milbemycins: A review
9. Spiroacetal from a key lactone intermediate leading to novel C24- and C25-substituted milbemycins
10. A Wittig approach to novel C24 and C25-substituted avermectins
11. Recent advances in avermectin research
12. Novel avermectins produced by mutational biosynthesis
13. Biosynthesis of the avermectins by Streptomyces avermitilis. Incorporation of labeled precursors
14. The preparation and biological activities of novel C-25 substituted avermectins
15. Activity of doramectin against nematode endoparasites of cattle
16. 4″-deoxy-4″-aminoavermectins with potent broad spectrum antiparasitic activities
17. Efficacy in sheep and pharmacokinetics in cattle that led to the selection of Eprinomectin as a topical endectocide for cattle
18. Eprinomectin: A novel avermectin for use as a topical endectocide for cattle
19. Structure-activity relationships of the avermectins and milbemycins
20. Residual foliar toxicity of 4"-epi-methylamino-4"-deoxyavermectin B1 hydrochloride (MK-243) and selected commercial insecticides to adult hymenopterous parasites, Pteromalus puparum (Hymen-optera: Pteromalidae) and Cotesia orobenae (Hymenoptera: Braconidae)
21. Synthesis and biological activity of 13-epi-avermectins: Potent anthelmintic agents with an increased margin of safety
22. Synthesis and anthelmintic activity of 13-alkoxymilbemycin derivatives
23. Avermectins and flea control: Structure-activity relationships and the selection of sleamectin for development as an endectocide for companion animals
24. The identification of selamectin: A novel avermectin endectocide for dogs and cats
25. Efficacy of selamectin, fipronil imidacloprid and lufenuron/milbemycin against Ctenocephalides fells in dogs
26. Efficacy of selamectin against Dermacentor variabilis ticks on dogs in laboratory and field studies
27. Efficacy of selamectin against adult Rhipicephalis sanguineus ticks on dogs
28. Avermectin binding in Caenorhabditis elegans. A two-state model for the avermectin binding site
29. Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes
30. Expression of a glutamate-activated chloride current in Xenopus oocytes injected with Caenorhabditis elegans RNA: Evidence for modulation by avermectin
31. 1a on insect muscle
32. A patch-clamp study of effects of dihydroavermectin on Ascaris muscle
33. Studies involving avermectin and the 4-aminobutyric acid (GABA) receptor of Ascaris suum muscle
34. Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes
35. The mechanism of action of avermectins in Caenorhabditis elegans: Correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity
36. 3H]ivermectin binding sites
37. Nodulisporic acid A, a novel and potent insecticide from a Nodulisporium sp. isolation, structure determination, and chemical transformations
38. Bafilolides, potent inhibitors of the motility and development of the free-living stages of parasitic nematodes
39. Structure of the sodium and potassium ion activated adenosinetriphosphatase inhibitor L-681,110
40. Affinity probes for the avermectin binding proteins
41. Solubilization and characterization of a high affinity ivermectin binding site from Caenorhabditis elegans
42. Photoaffinity labeling of avermectin binding sites from Caenorhabditis elegans and Drosophila melanogaster
43. Immunoaffinity purification of avermectin-binding proteins from the free-living nematode Caenorhabditis elegans and the fruitfly Drosophila melanogaster
44. Anthelmintic resistance
45. In vitro activity ofparaherquamide against the free-living stages of Haemonchus contortus, Trichostrongylus colubriformis and Ostertagia circumcincta
46. Characterization of an avermectin resistant strain of Australian Haemonchus contortus
47. A field case of ivermectin resistance in ostertagia of sheep
48. Ivermectin resistance
49. The structure of paraherquamide, a toxic metabohte from Penicillium paraherquei
50. Isolation and structure (X-ray analysis) of marcfortine A, a new alkaloid from Penicillium roqueforti
51. Anthelmintic activity of paraherquamide in sheep
52. Acute toxicity of paraherquamide and its potential as an anthelmintic
53. Novel anthelmintic metabolites from an Aspergillus species; the aspergillimides
54. Sclerotiamide: A new member of the paraherquamide class with potent antiinsectan activity from the sclerotia of Aspergillus sclerotiorum
55. An improved synthesis of 14-alphahydroxy-15,16-dehydro-17-oxomarcfortine A; A key intermediate in the synthesis of 14-alpha-hydroxymarcfortine A
56. Concurrent infections with the ruminant nematodes Haemonchus contortus and Trichostrongylus colubriformis in jirds, Meriones unguiculatus, and use of this model for anthelmintic studies
57. Further novel metabolites of the paraherquamide family
58. Chemical modification of paraherquamide. 2. Replacement of the C-14 methyl group
59. Semi-synthesis of 2-deoxo and 3-epi-paraherquamide A
60. 3H]paraherquamide binding to Caenorhabditis elegans. Studies on a potent new anthelmintic agent
61. Ligands of the nicotinic acetylcholine receptor as insecticides
62. Anthelmintic profile of the cyclodepsipeptide PF1022A in in vitro and in vivo models
63. Ionophore and anthelmintic activity of PF 1022A, a cyclooctadepsipeptide, are not related
64. Characterization of subtypes of gamma-aminobutyric acid receptors in an Ascaris muscle preparation by binding assay and binding of PF1022A, a new anthelmintic, on the receptors
65. Solid-phase synthesis ofcyclooctadepsipeptide PF1022A analogues using a cyclization-cleavage method with oxime resin
66. Epsilon-lactam analogues of the anthelmintic cyclodepsipeptide PF1022A
67. Synthesis, conformational studies and anthelmintic activity of a constrained PF1022A analogue
68. PF1022A -A novel anthelmintic cyclooctadepsipeptide. Modification and exchange of the N-methyl leucine residues
69. Omphalotins B, C and D, nematicidal cyclopeptides from Omphalotus olearius. Absolute configuration of omphalotin A
70. The pharmacology of nematode FMR-Famide-related peptides
71. Synthesis and biological activity of anthelmintic thiadiazoles using an AF-2 receptor binding assay
72. Isolation of AF2 (KHEYLRFamide) from Caenorhabditis elegans: Evidence for the presence of more than one FMRFamide related peptide-encoding gene
73. Insecticide susceptibility of cat flea (Siphonaptera: Pulicidae) pupae
74. Zur Problematik von therapieresistanten fiohpopulationen am beispiel des stammes "cottontail"
75. The cat flea: Biology, ecology and control
76. Use of an artificial membrane system for feeding the cat flea (Ctenocephalides felis)
77. The cat flea - Biology, ecology and control
78. A novel approach to flea control on cats, using pyriproxyfen
79. Laboratory evaluation of two promising new insecticides which interfere with cuticle deposition
80. Chitin metabolism: A target for drugs against parasites
81. Impact of an orally administered insect growth regulator (lufenuron) on flea infestations of dogs in a controlled simulated home environment
82. Pharmacological characteristics of insect nicotinic acetylcholine receptor with its ion channel and the comparison of the effect of nicotinoids and neonicotinoids
83. Efficacy of nitenpyram flavored tablets for rapid removal of adult cat fleas, Ctenocephalides felis, on cats
84. Control of fleas on pets and in homes using lufenuron and nitenpyram
85. Efficacy of an adulticide used alone or in combination with an insect growth regulator for flea infestations of dogs housed in simulated home environments
86. Efficacy of imidacloprid to remove and prevent Ctenocephalides felis infestations on dogs and cats
87. Effects of imidacloprid on adult and larval stages of the flea Ctenocephalides fells after in vivo and in vitro application: A light- and electron-microscopy study
88. Imidacloprid and resolution of signs of flea allergy dermatitis in dogs
89. Ion channels as targets for insecticides
90. Fipronil insecticide: Novel photochemical desulflnylation with retention of neurotoxicity
91. Potent systemic efficacy of nodulisporic acid against fleas on dogs
92. Chemical modification of nodulisporic acid A: Preliminary structure-activity relationships
93. Systemic efficacy of nodulisporamides against fleas on dogs
94. A83543A-D, unique fermentation-derived tetracyclic macrolides
95. Biological characteristics of the spinosyns: A new class of naturally derived insect control agents
96. Studies on the mode of action of spinosad: Insect symptoms and physiological correlates
97. Studies on the mode of action of spinosad, the active ingredient in Tracer Insect Control
98. Isolation of a substance that supresses feeding in locusts
99. The structure of azadirachtin and 22,23-dihydro-23β-methoxyazadirachtin
100. Actions of azadirachtin, a plant allelochemical, against insects
101. Azadirachtin: An update
102. Effects of azadirachtin on Ctenocephalides felis in the dog and the cat
103. The effects of steroids and azadirachtin on the salivary gland and ovary of ixodid ticks
104. The effect of invertebrate hormones and potential hormone inhibitors on the third larval moult of the filarial nematode, Dirofilaria immitis, in vitro
105. Gastric ulceration in mature thoroughbred horses
106. Gastric ulcers in horses: A comparison of endoscopic findings in horses with and without clinical signs
107. Gastric ulceration in horses: 91 Cases (1987-1990)
108. The pathogenesis and prevalence of gastric ulceration in foals and horses
109. Cell-free synthesis of rat and rabbit gastric proton pump
110. Effects of a histamine type-2 receptor antagonist (BMY-25368) on gastric secretion in horses
111. Treatment of gastric ulcers in horses with histamine type 2 receptor antagonists
112. The effects of famotidine, ranitidine and magnesium hydroxide/aluminium hydroxide on gastric fluid pH in adult horses
113. Gastric ulceration syndrome in foals
114. Effects of single intravenously administered doses ofomeprazole and ranitidine on intragastric pH and plasma gastrin concentration in nonfed ponies
115. The mechanism of action of omeprazole - A survey of its inhibatory actions in vivo
116. Effects of omeprazole on healing of naturally occurring gastric ulcers in Thoroughbred racehorses
117. Comparison of the antisecretory effects ofomeprazole when administered intravenously, as acid-stable granules and as an oral paste in horses
118. Study of obesity in dogs visiting veterinary practices in the United Kingdom
119. Obesity: Occurrence, treatment, and prevention
120. Overweight cats: Prevalence and risk factors
121. Energy requirements of cats and dogs: What goes wrong?
122. Obesity in dogs. Compendium Contin
123. Pharmacological Treatment of Obesity: Therapeutic Strategies
124. Tissue distribution of beta 3-adrenergic receptor mRNA in man
125. Beta-3 adrenergic receptor antagonists for the treatment of obesity
126. Obesity modifies the adrenergic status of dog adipose tissue
127. Anti-obesity effects of selective agonists to the beta 3-adrenergic receptor in dogs. I. The presence of canine beta 3-adrenergic receptor and in vivo lipomobilization by its agonists
128. Beta 3-adrenoceptors in dog adipose tissue: Studies on their involvement in the lipomobilizing effect of catecholamines
129. Influences on body composition and mechanism of action of the β-adrenergic agonist BRL26830A
130. New Treatments for Arthritis
131. Nonsteroidal antiinfiammatory drugs and aspirin: Analyzing the scores
132. Are there differences among nonsteroidal antiinflammatory drugs - Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs
133. Nonsteroidal antiinfiammatory analgesics to manage acute pain in dogs and cats
134. Use ofcarprofen for the treatment of pain and inflammation in dogs
135. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes
136. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal antiinfiammatory drugs
137. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs
138. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal antiinfiammatory drugs
139. Mechanism of action of antiinflammatory drugs
140. In vitro and ex vivo whole blood evidence of selective cyclooxygenase-2 inhibition by Rimadyl (carprofen)
141. Biopharmaceutical evaluation of carprofen following single intravenous, oral and rectal doses in dogs
142. Amelioration of respiratory and circulatory changes in established endotexic-shock by ketoprofen